FP5Training site2002–2006
SIGLECS · Functional analysis of siglecs in pathological progression of multiple scerosis.
FP5 — Improving Human Research Potential
- Duration
- 2002-12-01 → 2006-11-30
- EU contribution
- €169,344
- Participants
- 1
- Scheme
- BUR
Lines connect the coordinator with its partners.
Project objective
The pathological role of disregulated single expression in the CNS will be investigated for multiple sclerosis.
Original text from CORDIS.
Participants
- CELLTECH R&D LTD · SLOUGHCoordinatorUnited Kingdom
Links
Data: CORDIS, © European Union